UroGen Pharma (URGN) Preferred Shares (2016)
UroGen Pharma (URGN) posted quarterly Preferred Shares of $13000.0 for Q4 2016.
UroGen Pharma (URGN) Preferred Shares (2016) Analysis & Trends
UroGen Pharma (URGN) has reported Preferred Shares for 1 consecutive years, with $13000.0 the latest figure, recorded in Q4 2016.
- Quarterly Preferred Shares changed N/A year-over-year to $13000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $13000.0 (changed N/A YoY) and the FY2016 annual result came in at $13000.0, changed N/A from the prior year.
- Preferred Shares was little changed at $13000.0 in Q4 2016 per URGN's latest filing.
- Over the last five years, Preferred Shares for URGN reached as high as $13000.0 in Q4 2016 and fell as low as $13000.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | UroGen Pharma | 2.13 Bn | 1.99 Bn | 46.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 13,000.00 |